NCT03880630

Brief Summary

Background \& Objective: Inspiratory muscle training (IMT) is known to improve strength and endurance of inspiratory muscles. However, clinical beneficial effects of IMT for patients with chronic respiratory disease remain inconclusive. The purposes of the study are to investigate in patients with chronic respiratory disease: (Year 1) main (diaphragm) and accessory inspiratory muscle (sternocleidomastoid muscle) activation pattern during various IMT loading using group-based trajectory modeling (GBTM); and (Year 2) effectiveness of individualized IMT program (based on results of Year 1) on clinical outcomes. Methods: (Year 1) Patients with chronic respiratory disease with inspiratory muscle weakness will be recruited for the study. Patients will perform 3 inspiratory loading tests (15%, 30%, and 50% of maximum inspiratory pressures) on 3 separate days with the sequence will be randomized. Surface electromyography (EMG) of diaphragm and sternocleidomastoid muscle will be used to use inspiratory muscle activation during various conditions. Other outcomes include maximum inspiratory pressure, and functional exercise capacity will be measured. Inspiratory muscle activation will be used for GBTM analysis. Patient will then be trained with individualized IMT program based on the GBTM analysis input form results of Year 1.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 14, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 19, 2019

Completed
1.6 years until next milestone

Study Start

First participant enrolled

October 6, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

March 18, 2021

Status Verified

March 1, 2020

Enrollment Period

3 months

First QC Date

March 14, 2019

Last Update Submit

March 16, 2021

Conditions

Outcome Measures

Primary Outcomes (9)

  • Diaphragm and Sternocleidomastoid muscle activation

    Root mean square values during different conditions

    through the completion of the inspiratory loading tests condition; it would take about 3 minutes

  • The mean median frequency of diaphragm and sternocleidomastoid muscle

    The power spectrum is divided into two equal areas of the frequency value by median frequency to exam muscle fatigability

    In five minute after the completion of the loaded inspiratory muscle test condition

  • Pulmonary function

    Forced expiratory volume in one second, forced vital capacity, residual volume, total lung capacity

    About five minutes to complete

  • Maximal inspiratory pressure test

    Maximal inspiratory pressure

    About three minutes to complete

  • Functional exercise capacity using the six-minute walk test

    The six-minute walk test is commonly performed to evaluate functional exercise capacity. The six-minute walk test was performed according to the guidelines, and the distance walked in the test presented as functional exercise capacity

    The six-minute walk test needs six minute to complete the test

  • Heart rate

    Heart rate is measured at rest, during six-minute walk test

    The six-minute walk test needs six minute to complete the test

  • Blood pressure

    systolic and diastolic pressure are measured at rest, after six-minute walk test

    Before and immediately after the six-minute walk test;it takes less than one minute to measure blood pressure

  • Perceived dyspnea

    Rating of perceived dyspnea is measured by using Borg scale at rest, during six-minute walk test, inspiratory loading tests. The most widely used tool is the "Borg scale", with rating ranges from 0 (nothing at all) to 10 (extremely dyspnea).

    It takes less than one minute to evaluate perceived dyspnea

  • Oxygen saturation

    Oxygen saturation is continuously monitored by pulse oximetry throughout six-minute walk test, inspiratory loading tests

    The six-minute walk test needs six minute to complete the test; through the completion of the inspiratory loading tests condition; it would take about 3 minutes

Study Arms (1)

Chronic respiratory disease

EXPERIMENTAL

Patients with chronic respiratory disease with inspiratory muscle weakness will be recruited for the study

Other: Inspiratory muscle training

Interventions

Patients will perform 3 inspiratory loading tests (15%, 30%, and 50% of maximum inspiratory pressures) on 3 separate days with the sequence will be randomized. Patient will then be trained with individualized IMT program based on the results of 3 inspiratory loading tests.

Chronic respiratory disease

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age \> 20 years old
  • has been diagnosis of chronic obstructive pulmonary disease with stable clinical condition with no infection or acute exacerbation in the previous four weeks
  • can cooperate with the measurements of this study

You may not qualify if:

  • any clinical diagnosis that will influence the measurement, including any history of
  • neuromyopathy
  • angina, acute myocardial infarction in the previous one month
  • pregnancy
  • participated in inspiratory muscle training program in the previous three months
  • any psychiatric or cognitive disorders, for example: Mini-Mental State Examination (MMSE) \< 24, that will disturb the communication and cooperation of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School & Graduate Institute of Physical Therapy, College of Medicine, NTU

Taipei, 100, Taiwan

Location

Study Officials

  • Li-Ying Wang, Phd

    National Taiwan University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 14, 2019

First Posted

March 19, 2019

Study Start

October 6, 2020

Primary Completion

December 31, 2020

Study Completion

December 31, 2020

Last Updated

March 18, 2021

Record last verified: 2020-03

Locations